Polaris Venture Management Co. V as of March 31, 2015
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 7 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 38.1 | $85M | 2.0M | 41.99 | |
| T2 Biosystems | 16.5 | $37M | 2.4M | 15.52 | |
| Cerulean Pharma | 13.2 | $30M | 3.3M | 9.01 | |
| Trevena | 11.0 | $25M | 3.8M | 6.52 | |
| Genocea Biosciences | 10.9 | $24M | 2.1M | 11.86 | |
| Fate Therapeutics (FATE) | 5.4 | $12M | 2.5M | 4.89 | |
| Bind Therapeutics | 5.0 | $11M | 2.0M | 5.49 |
